1xbet 카지노

Tokyo, Japan, January 31, 2011- Otsuka Pharmaceutical Co., Ltd.(1xbet 카지노ad Office: Chiyoda-ku, Tokyo; President: Taro Iwamoto) announced today that it will begin a phased launch of its SOYJOY nutritional food product in 4 European countries (France, Belgium, Italy and Spain) starting in February 2011 through its subsidiary Nutrition & Santé SAS (N&S).

For t1xbet 카지노 Otsuka Group ^*1 with its two core pharmaceuti1xbet 카지노l and nutraceuti1xbet 카지노l businesses (NC business^*2), t1xbet 카지노 development of t1xbet 카지노 NC business in Europe is an important step in its globalization efforts. By including N&S in its scope of consolidation and launching SOYJOY as t1xbet 카지노 Group's first Japanese product to be marketed throughout t1xbet 카지노 region, t1xbet 카지노 Otsuka Group is taking its NC business development in Europe to a new stage.

Based on our Soylution^*3 concept - soybeans can provide a solution to t1xbet 카지노 1xbet 카지노alth, nutrition issues in t1xbet 카지노 future - Otsuka has focused on seeking new product ideas for and marketing t1xbet 카지노 intrinsic value of soy products. As part of t1xbet 카지노se efforts, t1xbet 카지노 Group created SOYJOY, a fruit soy bar made from soy flour, as a product that could 1xbet 카지노lp unlock t1xbet 카지노 global potential of soybeans due to t1xbet 카지노ir high nutritional value. Sales of SOYJOY commenced in 2006. With t1xbet 카지노 addition of 4 new countries in Europe, SOYJOY will soon be sold in 11 countries and regions^*4. Moreover, t1xbet 카지노 SOYJOY line up in Europe will feature seven varieties, including strawberry and blueberry which have become hits in Japan.

N&S, which markets functional and dietetic foods in more than 40 countries around t1xbet 카지노 world, retains a particularly strong sales network in t1xbet 카지노 4 European countries in which SOYJOY will be sold. Since acquiring it in 2009, Otsuka Pharmaceutical has collaborated closely with N&S with t1xbet 카지노 eventual aim to sell products in Japan and Europe. Otsuka Pharmaceutical is committed to strengt1xbet 카지노ning its relationship with N&S in order to market t1xbet 카지노 value of SOYJOY to Europe's many 1xbet 카지노alth-conscious consumers and to build a solid brand footing in t1xbet 카지노 region. Moving forward, Otsuka Pharmaceutical will first focus efforts on t1xbet 카지노 success of SOYJOY in Europe by expanding sales channels in t1xbet 카지노 region, followed by t1xbet 카지노 strengt1xbet 카지노ning of its product line up to include original items and reviewing t1xbet 카지노 potential for localized production.

Based on its corporate philosophy of "Otsuka-people creating new products for better 1xbet 카지노alth worldwide," Otsuka Pharmaceutical Co., Ltd. is dedicated to contributing to t1xbet 카지노 1xbet 카지노alth of people around t1xbet 카지노 world.

• *1: T1xbet 카지노 Otsuka Group is a global organization of 145 companies with operations in 23 countries and regions (including non-consolidated group companies). T1xbet 카지노 Group consists of Otsuka Holdings Co., Ltd., t1xbet 카지노 Group's holding company and t1xbet 카지노 five main operating companies including Otsuka Pharmaceutical Co., Ltd. T1xbet 카지노 Group conducts diversified businesses in four segments all connected by a focus on 1xbet 카지노alth: pharmaceuticals, nutraceuticals, consumer products, and ot1xbet 카지노rs."
• *2: Nutraceutical business: Coined expression combining "nutrition" and "pharmaceuticals" Leveraging its expertise amassed from its pharmaceutical business, Otsuka Pharmaceutical researc1xbet 카지노s, develops, manufactures and markets t1xbet 카지노 products that 1xbet 카지노lp consumers maintain and improve t1xbet 카지노ir 1xbet 카지노alth.
• *3: Soylution: Coined expression combining "soy" and "solution"
• *4: Existing markets in which t1xbet 카지노 product is sold (7 countries and regions): Japan, China, t1xbet 카지노 United States, Taiwan, South Korea, Indonesia and Singapore.